CTOs on the Move

Marker Therapeutics

www.markertherapeutics.com

 
We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker`s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient`s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Marker Therapeutics raised $56.5M on 03/12/2021

Similar Companies

Cary Pharmaceuticals Inc

Cary Pharmaceuticals Inc is a Great Falls, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

I Holland Americas

I Holland Americas is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nova-Tech Engineering Inc

Nova-Tech Engineering Inc is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GreenwichBiosciences

Greenwich Biosciences is the leader in researching cannabinoid medicines for rare epilepsies like Dravet Syndrome, LGS, TSC, and others.

Pharma Pac

Pharma Pac is a De Kalb, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.